| Modulators of cystic fibrosis transmembrane conductance regulator |
2023-3-07 |
2023-4-06 |
|
| Materials and methods for the treatment of Duchenne muscular dystrophy |
2022-12-14 |
2023-3-15 |
|
| Differentiation of pancreatic endocrine cells |
2022-11-16 |
2023-3-23 |
|
| Stem cell derived islet differentiation |
2022-11-14 |
2023-3-16 |
|
| Method for treating cancer using a combination of DNA damaging agents and ATR … |
2022-10-20 |
2022-11-24 |
|
| Materials and methods for treatment of pain related disorders |
2022-10-19 |
2022-12-22 |
|
| Methods and apparatus to facilitate 3d object visualization and manipulation … |
2022-9-29 |
2023-1-26 |
|
| Macrocycles as modulators of cystic fibrosis transmembrane conductance … |
2022-9-15 |
2022-10-06 |
|
| CRYSTALLINE FORMS OF C21H22Cl2N4O2 |
2022-9-05 |
2022-9-29 |
|
| Method for treating cancer using combination of dna-damaging agents and dna-pk … |
2022-7-25 |
2022-9-15 |
|
| Materials and methods for treatment of pain-related disorders |
2022-7-07 |
2022-9-08 |
|
| N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of … |
2022-6-03 |
2023-1-12 |
|
| Devices and methods for delivering therapeutics |
2022-5-04 |
2022-10-20 |
|
| Modified membrane type serine protease 1 (mtsp-1) polypeptides and methods of … |
2022-3-02 |
2022-3-24 |
|
| Compositions and Methods for Treatment of Disorders Associated with Repetitive … |
2022-2-25 |
2022-6-16 |
|
| Pancreatic differentiation |
2022-2-11 |
2022-7-28 |
|
| Materials and methods for treatment of hemoglobinopathies |
2022-2-02 |
2022-7-07 |
|
| Materials and methods for treatment of hemoglobinopathies |
2022-1-26 |
2022-8-18 |
|
| Pharmaceutical compositions for treating cftr-mediated diseases |
2021-12-28 |
2022-3-02 |
|
| Enhanced differentiation of beta cells |
2021-12-23 |
2022-7-28 |
|
| Compositions and methods for editing beta-globin for treatment of … |
2021-12-17 |
2022-7-21 |
|
| Methods of treatment for cystic fibrosis |
2021-12-09 |
2022-6-16 |
|
| Modulators of cystic fibrosis transmembrane conductance regulator |
2021-11-17 |
2023-3-30 |
|
| Modulator of cystic fibrosis transmembrane conductance regulator, … |
2021-10-20 |
2022-9-29 |
|
| Method for treating cancer using a combination of chk1 and atr inhibitors |
2021-9-20 |
2022-8-11 |
|
| Methods, compositions and kits for increasing genome editing efficiency |
2021-9-17 |
2023-4-13 |
2023-4-13 |
| Formulations of azaindole compounds |
2021-9-17 |
2021-12-16 |
|
| Methods, compositions and kits for increasing genome editing efficiency |
2021-9-17 |
2021-10-14 |
|
| Pharmaceutical compositions for treating cystic fibrosis |
2021-9-15 |
2022-8-18 |
|
| Pharmaceutical composition and administrations thereof |
2021-9-15 |
2022-8-04 |
|
| Compositions and Methods for Treatment of Duchenne Muscular Dystrophy |
2021-9-08 |
2022-3-31 |
|
| Compositions and methods for treatment of duchenne muscular dystrophy |
2021-9-08 |
2022-3-17 |
|
| Inhibitors of apol1 and methods of using same |
2021-8-26 |
2022-3-03 |
|
| Crystalline forms of cftr modulators |
2021-8-12 |
2022-2-17 |
|
| Modulators of cystic fibrosis transmembrane conductance regulator |
2021-8-06 |
2023-4-13 |
|
| Modulators of cystic fibrosis transmembrane conductance regulator |
2021-8-06 |
2023-4-06 |
|
| Modulator of cystic fibrosis transmembrane conductance regulator, … |
2021-8-03 |
2023-4-06 |
2023-4-06 |
| Compounds useful as inhibitors of atr kinase and combination therapies thereof |
2021-8-03 |
2022-7-28 |
|
| In vitro differentiation of pancreatic endocrine cells |
2021-7-30 |
2023-3-02 |
|
| Processes for preparing modulators of alpha-1 antitrypsin |
2021-7-26 |
2022-2-03 |
|
| Process of conducting high throughput testing high performance liquid … |
2021-7-26 |
2021-10-29 |
|
| Methods of preparing inhibitors of influenza viruses replication |
2021-7-12 |
2021-8-05 |
|
| Top- mounted mud-telemetry pulser assembly for downhole communications, and … |
2021-7-07 |
2022-5-09 |
|
| Methods of preparing pharmaceutical compositions for treatment of cftr mediated … |
2021-7-06 |
2021-10-14 |
|
| Modulators of atp-binding cassette transporters |
2021-6-29 |
2022-5-19 |
|
| Complement factor i-related compositions and methods |
2021-6-14 |
2021-12-23 |
|
| Inhibitors of apol1 and use of the same |
2021-6-11 |
2021-12-16 |
|
| Solid forms of apol1 inhibitor and using the same |
2021-6-11 |
2021-12-16 |
|
| Inhibitors of apol1 and methods of using same |
2021-6-11 |
2023-1-19 |
|
| Gene-editing systems for editing a cystic fibrosis transmembrane regulator ( … |
2021-6-04 |
2021-12-30 |
|
| Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) … |
2021-5-28 |
2022-2-03 |
|
| Pyrrolo [2,3-f ] indazole and 2,4,5, 10-tetraazatricyclo [7.3.0.03,7] dodec-1, … |
2021-4-02 |
2023-3-10 |
|
| Modulators of alpha-1 antitrypsin |
2021-4-02 |
2022-10-27 |
|
| Modulators of alpha-1 antitrypsin |
2021-4-02 |
2022-10-20 |
|
| 7- or 8-hydroxy-isoquinoline and 7- or 8-hydroxy-quinoline derivatives as alpha … |
2021-4-02 |
2023-2-08 |
|
| Indole derivatives as alpha-1 -antitrypsin modulators for treating alpha-1 - … |
2021-4-02 |
2022-11-03 |
|
| Modulators of alpha-1 antitrypsin |
2021-4-02 |
2021-10-07 |
|
| Modulators of atp-binding cassette transporters |
2021-3-30 |
2023-3-30 |
|
| Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane … |
2021-3-17 |
2021-10-07 |
|
| Methods of treating APOL-1 dependent focal segmental glomerulosclerosis |
2021-3-05 |
2022-9-22 |
|
| Methods of treating APOL-1 dependent focal segmental glomerulosclerosis |
2021-3-05 |
2023-4-13 |
|
| Pteridinone compounds and uses thereof |
2021-3-01 |
2022-11-17 |
|
| Compounds useful as inhibitors of atr kinase |
2021-2-25 |
2023-2-02 |
|
| Modulators of atp-binding cassette transporters |
2021-2-22 |
2022-12-29 |
|
| Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) … |
2021-2-12 |
2022-11-10 |
|
| Substituted quinoxaline dna-pk inhibitors |
2021-2-09 |
2021-8-05 |
|
| Solid forms of apol1 inhibitor and methods of using same |
2021-2-03 |
2021-8-12 |
|
| Methods of treating alpha-1 antitrypsin deficiency |
2021-1-29 |
2023-3-30 |
|
| Visualizing and evaluating 3d cross-sections |
2021-1-29 |
2022-12-07 |
|
| Inhibitors of apol1 and methods of using same |
2021-1-28 |
2022-12-07 |
|
| Pyrazolo[1,5-a]pyrimidines useful as inhibitors of atr kinase for the treatment … |
2020-12-23 |
2021-2-19 |
|
| Gcn2 inhibitors and uses thereof |
2020-12-15 |
2022-10-27 |
|
| Mannose Derivatives for Treating Bacterial Infections |
2020-12-14 |
2022-5-05 |
|
| Substituted tetrahydrofurans as sodium channel modulators |
2020-12-04 |
2022-8-26 |
|
| Solid Forms of (R)-1(2,2-Difluorobenzo[D][1,3]Dioxol-5-yl)-N-(1-(2,3- … |
2020-11-25 |
2021-11-04 |
|
| Inhibitors of influenza viruses replication |
2020-10-29 |
2021-2-11 |
|
| Removable and replaceable anchored tunnel gasket |
2020-10-28 |
2021-3-18 |
|
| Pyridone amide as regulator of sodium channel |
2020-10-07 |
2021-1-07 |
|
| Methods of enhancing stem cell differentiation into beta cells |
2020-9-02 |
2021-7-01 |
|
| Antiproliferation compounds and uses thereof |
2020-8-27 |
2022-9-13 |
2022-9-13 |
| Process of producing cycloalkylcarboxamido-indole compounds |
2020-8-26 |
2021-8-05 |
|
| Treating cancer with atr inhibitors |
2020-8-26 |
2020-12-17 |
|
| Prodrugs of pyridone amides useful as modulators of sodium channels |
2020-8-20 |
2020-12-03 |
|
| Compounds useful as inhibitors of atr kinase |
2020-8-17 |
2021-2-04 |
|
| Crystalline forms of cftr modulators |
2020-8-13 |
2022-6-22 |
|
| Modulators of cystic fibrosis transmembrane conductance regulator |
2020-8-13 |
2022-6-03 |
|
| Process of making CFTR modulators |
2020-8-13 |
2022-3-31 |
|
| Process for recycling components of a confined space metal container |
2020-8-13 |
2021-2-18 |
|
| Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) … |
2020-8-13 |
2020-9-28 |
|
| Modulators of cystic fibrosis transmembrane conductance regulator |
2020-8-13 |
2022-6-22 |
|
| Materials and methods for treatment of hemoglobinopathies |
2020-6-23 |
2021-10-14 |
|
| Gcn2 inhibitors and uses thereof |
2020-6-22 |
2021-2-11 |
|
| Compositions and methods for editing beta-globin for treatment of … |
2020-6-17 |
2022-1-06 |
|
| Inhibitor of duplication of influenza virus |
2020-6-05 |
2020-8-27 |
|
| Condensed tryciclic pyrroles as alpha-1 antitrypsin modulators |
2020-5-14 |
2020-12-10 |
|
| Crispr/cas all-in-two vector systems for treatment of dmd |
2020-5-08 |
2021-2-18 |
|
| Islet cell manufacturing compositions and methods of use |
2020-5-01 |
2021-1-21 |
|
| Gene editing systems for modifying the SCN9A or SCN10A genes and how to use … |
2020-4-10 |
2022-5-25 |
|
| Pharmaceutical composition and administrations thereof |
2020-4-07 |
2021-1-28 |
|
| Multicompartment macroencapsulation devices |
2020-4-02 |
2020-10-08 |
|